Lung Cancer
516-005: A Randomized Phase 3 Study of Sitravatinib in Combination with Nivolumab Versus Docetaxel in Patients with Advanced Non-Squamous Non-Small Cell Lung Cancer with Disease Progression On or After Platinum-Based Chemotherapy and Checkpoint Inhibitor Therapy (SAPPHIRE)
- Details
ClinicalTrials.gov ID:
NCT03906071
Diagnosis Type:
NA
USOR Number:
- Address
1580 Beam Avenue
Maplewood, MN 55109
P: (651) 779-7978